Dr. Reddy's Laboratories Limited (RDDA) — Capital Reinvestment Ratio
Dr. Reddy's Laboratories Limited (RDDA) has a Capital Reinvestment Ratio of 0.67x as of December 2025, meaning it reinvests 1% of its operating cash flow (€10.91 Billion) in capital expenditures (€7.32 Billion). Check RDDA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dr. Reddy's Laboratories Limited Capital Reinvestment Ratio (2017–2025)
This chart tracks Dr. Reddy's Laboratories Limited's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see Dr. Reddy's Laboratories Limited operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year Capital Reinvestment Ratio for Dr. Reddy's Laboratories Limited from 2017 to 2025. See Dr. Reddy's Laboratories Limited (RDDA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.74x | €46.43 Billion | €34.40 Billion | ▲ +22.7% |
| 2024 | 0.60x | €45.43 Billion | €27.43 Billion | ▲ +88.4% |
| 2023 | 0.32x | €58.88 Billion | €18.87 Billion | ▼ -38.6% |
| 2022 | 0.52x | €28.11 Billion | €14.66 Billion | ▲ +91.2% |
| 2021 | 0.27x | €35.70 Billion | €9.74 Billion | ▲ +68.0% |
| 2020 | 0.16x | €29.84 Billion | €4.85 Billion | ▼ -33.0% |
| 2019 | 0.24x | €28.70 Billion | €6.96 Billion | ▼ -53.0% |
| 2018 | 0.52x | €18.03 Billion | €9.29 Billion | ▼ -9.7% |
| 2017 | 0.57x | €21.51 Billion | €12.28 Billion | — |